Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HIV genotyping study launched in Brazil

This article was originally published in Clinica

Executive Summary

Brazil is to launch a study to assess drug resistance in the HIV-1 virus genome, as part of the country's first major evaluation of the clinical utility of routine genotyping. The one-year study will involve 6,000 patients who have twice failed to respond to the Highly Active AntiRetroviral Therapy (HAART) drug combination regime.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT071163

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel